FibroGen Balance Sheet Health
Financial Health criteria checks 0/6
FibroGen has a total shareholder equity of $-162.2M and total debt of $89.7M, which brings its debt-to-equity ratio to -55.3%. Its total assets and total liabilities are $423.5M and $585.7M respectively.
Key information
-55.3%
Debt to equity ratio
US$89.70m
Debt
| Interest coverage ratio | n/a |
| Cash | US$235.59m |
| Equity | -US$162.20m |
| Total liabilities | US$585.73m |
| Total assets | US$423.53m |
Recent financial health updates
Health Check: How Prudently Does FibroGen (NASDAQ:FGEN) Use Debt?
Feb 13
Health Check: How Prudently Does FibroGen (NASDAQ:FGEN) Use Debt?
Oct 09Is FibroGen (NASDAQ:FGEN) Using Debt Sensibly?
Jul 06Is FibroGen (NASDAQ:FGEN) Using Debt Sensibly?
Mar 31Recent updates
FibroGen, Inc.'s (NASDAQ:FGEN) Share Price Boosted 35% But Its Business Prospects Need A Lift Too
Mar 22There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 148% Share Price Rise
Feb 05FibroGen, Inc. (NASDAQ:FGEN) Held Back By Insufficient Growth Even After Shares Climb 42%
Dec 22A Look At The Intrinsic Value Of FibroGen, Inc. (NASDAQ:FGEN)
Nov 24Revenues Not Telling The Story For FibroGen, Inc. (NASDAQ:FGEN)
Apr 18Health Check: How Prudently Does FibroGen (NASDAQ:FGEN) Use Debt?
Feb 13The FibroGen, Inc. (NASDAQ:FGEN) Analysts Have Been Trimming Their Sales Forecasts
Nov 12Health Check: How Prudently Does FibroGen (NASDAQ:FGEN) Use Debt?
Oct 09FibroGen completes patient enrollment for Roxadustat to treat anemia in patients
Aug 26FibroGen Q2 2022 Earnings Preview
Aug 05Is FibroGen (NASDAQ:FGEN) Using Debt Sensibly?
Jul 06Is FibroGen (NASDAQ:FGEN) Using Debt Sensibly?
Mar 31Time To Worry? Analysts Are Downgrading Their FibroGen, Inc. (NASDAQ:FGEN) Outlook
Mar 05Is FibroGen (NASDAQ:FGEN) Using Debt In A Risky Way?
Dec 08News Flash: 10 Analysts Think FibroGen, Inc. (NASDAQ:FGEN) Earnings Are Under Threat
Aug 12Downgrade: Here's How Analysts See FibroGen, Inc. (NASDAQ:FGEN) Performing In The Near Term
Jul 17Is FibroGen A Buy Going Into Roxa AdCom?
Jul 13FibroGen in pact for three HiFiBiO programs in cancer and autoimmune disease
Jun 17Financial Position Analysis
Short Term Liabilities: FGEN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: FGEN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: FGEN has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: FGEN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FGEN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: FGEN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.9% each year